Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_3
2
33%
Ph phase_4
1
17%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
2(66.7%)
Phase 4Post-market surveillance
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

3 of 6 finished

Non-Completion Rate

50.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(3)
Terminated(3)

Detailed Status

Completed3
Withdrawn2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (66.7%)
Phase 41 (33.3%)

Trials by Status

completed350%
terminated117%
withdrawn233%

Recent Activity

0 active trials
Showing 5 of 6
withdrawnphase_3

Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine

NCT01390324
withdrawnphase_3

Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine.

NCT01726920
completed

Special Drug Use Investigation for AMERGE® Tablet (Long-term)

NCT01332383
terminatedphase_4

Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order

NCT00282165
completed

Sumatriptan and Naratriptan Pregnancy Registry

NCT01059604
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT01390324Phase 3

Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine

Withdrawn
NCT01726920Phase 3

Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine.

Withdrawn
NCT01332383

Special Drug Use Investigation for AMERGE® Tablet (Long-term)

Completed
NCT00282165Phase 4

Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order

Terminated
NCT01059604

Sumatriptan and Naratriptan Pregnancy Registry

Completed
NCT01376193

Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6